Brevan Howard Capital Management »

Nurix Therapeutics shares owned by Brevan Howard Capital Management

Quarter-by-quarter ownership of Nurix Therapeutics (NRIX) shares owned by Brevan Howard Capital Management from 13F filings

Historical chart of Brevan Howard Capital Management investment in Nurix Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nurix Therapeutics held by Brevan Howard Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nurix Therapeutics by Brevan Howard Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $691k 75k 9.24
2025-06-30 $716k 63k 11.39
2024-12-31 $405k 22k 18.84
2023-12-31 $114k 11k 10.32

More positions owned by Brevan Howard Capital Management

Alphabet Cap Stk Cl C Call Option (GOOG)
Ishares Bitcoin Trust Etf Shs Ben Int Call Option (IBIT)
Pdd Holdings Sponsored Ads Call Option (PDD)
Microsoft Corporation Call Option (MSFT)
Meta Platforms Cl A Call Option (META)
Ishares Tr Msci Emg Mkt Etf Call Option (EEM)
Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
Ishares Tr Iboxx Inv Cp Etf Call Option (LQD)
Dbx Etf Tr Xtrack Hrvst Csi Call Option (ASHR)
NVIDIA Corporation Call Option (NVDA)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Coinbase Global Com Cl A Call Option (COIN)
Baidu Spon Adr Rep A Call Option (BIDU)
Agnico Call Option (AEM)
Alphabet Cap Stk Cl A Put Option (GOOGL)

View all positions for Brevan Howard Capital Management

Top funds holding Nurix Therapeutics

FMR
BlackRock
Deep Track Capital
Vanguard Group
Baker Bros. Advisors
Commodore Capital
Redmile Group
Vestal Point Capital
Point72 Asset Management
State Street Corporation
Soleus Capital Management
Kynam Capital Management
Morgan Stanley
Pictet Asset Management Holding SA
Geode Capital Management

View all funds holding Nurix Therapeutics